147 related articles for article (PubMed ID: 33658848)
1. Naa10p Enhances Chemosensitivity to Cisplatin in Oral Squamous Cell Carcinoma Cells.
Sun L; Wang K; Peng L; Zhang J; Yang J; Zhao J; Xu J; Zheng J; Zeng Y
Cancer Manag Res; 2021; 13():1843-1851. PubMed ID: 33658848
[TBL] [Abstract][Full Text] [Related]
2. LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression.
Fang Z; Zhao J; Xie W; Sun Q; Wang H; Qiao B
Cancer Med; 2017 Dec; 6(12):2897-2908. PubMed ID: 29125238
[TBL] [Abstract][Full Text] [Related]
3. Inverse correlation between Naa10p and Pirh2 expression and the combined prognostic value in oral squamous cell carcinoma patients.
Zheng J; Wang F; Yang Y; Xu J; Yang J; Wang K; Liu Y; Du G; Zeng Y
J Oral Pathol Med; 2019 Sep; 48(8):686-695. PubMed ID: 31134698
[TBL] [Abstract][Full Text] [Related]
4. MiR-132 inhibits migration and invasion and increases chemosensitivity of cisplatin-resistant oral squamous cell carcinoma cells via targeting TGF-β1.
Chen L; Zhu Q; Lu L; Liu Y
Bioengineered; 2020 Dec; 11(1):91-102. PubMed ID: 31906769
[TBL] [Abstract][Full Text] [Related]
5. MiR-149-5p regulates cisplatin chemosensitivity, cell growth, and metastasis of oral squamous cell carcinoma cells by targeting TGFβ2.
Luo K; He J; Yu D; Açil Y
Int J Clin Exp Pathol; 2019; 12(10):3728-3739. PubMed ID: 31933761
[TBL] [Abstract][Full Text] [Related]
6. Clinical value of Naa10p and CEA levels in saliva and serum for diagnosis of oral squamous cell carcinoma.
Zheng J; Sun L; Yuan W; Xu J; Yu X; Wang F; Sun L; Zeng Y
J Oral Pathol Med; 2018 Oct; 47(9):830-835. PubMed ID: 30028540
[TBL] [Abstract][Full Text] [Related]
7. Naa10p and IKKα interaction regulates EMT in oral squamous cell carcinoma via TGF-β1/Smad pathway.
Lv S; Luo T; Yang Y; Li Y; Yang J; Xu J; Zheng J; Zeng Y
J Cell Mol Med; 2021 Jul; 25(14):6760-6772. PubMed ID: 34060226
[TBL] [Abstract][Full Text] [Related]
8. LncRNA XIST promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by downregulating miR-27b-3p.
Ma SQ; Wang YC; Li Y; Li XY; Yang J; Sheng YM
J Biol Regul Homeost Agents; 2020; 34(6):1993-2001. PubMed ID: 33191714
[TBL] [Abstract][Full Text] [Related]
9. High expression of Naa10p associates with lymph node metastasis and predicts favorable prognosis of oral squamous cell carcinoma.
Zeng Y; Zheng J; Zhao J; Jia PR; Yang Y; Yang GJ; Ma JF; Gu YQ; Xu J
Tumour Biol; 2016 May; 37(5):6719-28. PubMed ID: 26662107
[TBL] [Abstract][Full Text] [Related]
10. LncRNA HOXA11-AS Promotes Proliferation and Cisplatin Resistance of Oral Squamous Cell Carcinoma by Suppression of miR-214-3p Expression.
Wang X; Li H; Shi J
Biomed Res Int; 2019; 2019():8645153. PubMed ID: 31275988
[TBL] [Abstract][Full Text] [Related]
11. Expression of caveolin-1 and its correlation with cisplatin sensitivity in oral squamous cell carcinoma.
Nakatani K; Wada T; Nakamura M; Uzawa K; Tanzawa H; Fujita S
J Cancer Res Clin Oncol; 2005 Jul; 131(7):445-52. PubMed ID: 15856296
[TBL] [Abstract][Full Text] [Related]
12. Effect of microRNA-27b on cisplatin chemotherapy sensitivity of oral squamous cell carcinoma via FZD7 signaling pathway.
Liu B; Cao G; Dong Z; Guo T
Oncol Lett; 2019 Jul; 18(1):667-673. PubMed ID: 31289540
[TBL] [Abstract][Full Text] [Related]
13. Proteasome inhibitor MG132 enhances the sensitivity of human OSCC cells to cisplatin via a ROS/DNA damage/p53 axis.
Zheng Z; Wang X; Chen D
Exp Ther Med; 2023 May; 25(5):224. PubMed ID: 37123203
[TBL] [Abstract][Full Text] [Related]
14. Piwi-Interacting RNA1037 Enhances Chemoresistance and Motility in Human Oral Squamous Cell Carcinoma Cells.
Li G; Wang X; Li C; Hu S; Niu Z; Sun Q; Sun M
Onco Targets Ther; 2019; 12():10615-10627. PubMed ID: 31824169
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of cisplatin cytotoxicity by SAHA involves endoplasmic reticulum stress-mediated apoptosis in oral squamous cell carcinoma cells.
Suzuki M; Endo M; Shinohara F; Echigo S; Rikiishi H
Cancer Chemother Pharmacol; 2009 Nov; 64(6):1115-22. PubMed ID: 19280190
[TBL] [Abstract][Full Text] [Related]
16. Ginkgolide B Regulates CDDP Chemoresistance in Oral Cancer via the Platelet-Activating Factor Receptor Pathway.
Kawasaki K; Kasamatsu A; Ando T; Saito T; Nobuchi T; Nozaki R; Iyoda M; Uzawa K
Cancers (Basel); 2021 Dec; 13(24):. PubMed ID: 34944919
[TBL] [Abstract][Full Text] [Related]
17. Combined arsenic trioxide-cisplatin treatment enhances apoptosis in oral squamous cell carcinoma cells.
Nakaoka T; Ota A; Ono T; Karnan S; Konishi H; Furuhashi A; Ohmura Y; Yamada Y; Hosokawa Y; Kazaoka Y
Cell Oncol (Dordr); 2014 Apr; 37(2):119-29. PubMed ID: 24599717
[TBL] [Abstract][Full Text] [Related]
18. Antitumor effect of poly lactic acid nanoparticles loaded with cisplatin and chloroquine on the oral squamous cell carcinoma.
Li Q; Liu X; Yan W; Chen Y
Aging (Albany NY); 2020 Dec; 13(2):2593-2603. PubMed ID: 33323546
[TBL] [Abstract][Full Text] [Related]
19. Collagen gel droplet-embedded culture drug sensitivity testing in squamous cell carcinoma cell lines derived from human oral cancers: Optimal contact concentrations of cisplatin and fluorouracil.
Sakuma K; Tanaka A; Mataga I
Oncol Lett; 2016 Dec; 12(6):4643-4650. PubMed ID: 28105171
[TBL] [Abstract][Full Text] [Related]
20. Copper efflux transporter (ATP7B) contributes to the acquisition of cisplatin-resistance in human oral squamous cell lines.
Yoshizawa K; Nozaki S; Kitahara H; Ohara T; Kato K; Kawashiri S; Yamamoto E
Oncol Rep; 2007 Oct; 18(4):987-91. PubMed ID: 17786364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]